Liver enzymes among COVID-19 patients in Al-Ahsa region of Saudi Arabia.
Omar Ahmed Al-OmairPublished in: BMJ open gastroenterology (2023)
This large cohort of 442 patients has shown that liver damage may be an independent prognostic factor for morbidities and mortality among COVID-19 patients. It also showed the importance of liver function enzymes screening as a predictor for the outcome of those patients.